There is emerging evidence that the systemic inflammatory processes of IBD may contribute to the pathogenesis of cardiovascular diseases through increasing inflammatory mediators such as reactive oxygen species, C-reactive protein (CRP), and pro-inflammatory cytokines [61,62]. Here, CRP is linked to inflammatory bowel disease.